Actively Recruiting
FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients
Led by Amsterdam UMC, location VUmc · Updated on 2025-04-06
36
Participants Needed
1
Research Sites
136 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The FeelFit study aims to assess the effectiveness of High-Intensity Interval Training (HIIT) in improving self-reported physical fitness in adult brain tumor patients during periods of stable disease, as compared to a waiting-list control group. Furthermore, several secondary and exploratory outcomes will be evaluated. The study is part of the GRIP (GuaRding quality survivorshiP) project, which aims to improve quality of life in brain tumor patients.
CONDITIONS
Official Title
FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Reduced self-reported physical fitness
- At least 18 years old
- Diagnosed with a primary brain tumor
- Stable disease with no signs of tumor progression
- No oncological treatment for at least two months before joining
- Able to speak, read, and write in Dutch
You will not qualify if you...
- Karnofsky Performance Score less than 70
- Participated in a High-Intensity Interval Training (HIIT) program less than 1 month ago
- Medical reasons that make exercise unsafe
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
VU University Medical Centers, location VUmc
Amsterdam, Netherlands, 1081 HV
Actively Recruiting
Research Team
M
Marieke Blom, Msc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here